Candriam SCA’s Spectrum Pharmaceuticals Inc SPPI Stock Holding History

Candriam SCA’s Portfolio SPPI Stock Details SPPI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q2	–	Sell	-990,882	Closed	-$3.53M	–	885
2020 Q1	$3.53M	Hold	990,882	–	–	0.04%	428
2019 Q4	$3.61M	Sell	990,882 -26,518	-3%	-$214K	0.04%	442
2019 Q3	$8.44M	Sell	1,017,400 -50,000	-5%	-$404K	0.11%	214
2019 Q2	$9.15M	Buy	1,067,400 +22,500	+2%	+$201K	0.11%	205
2019 Q1	$11.2M	Buy	1,044,900 +65,075	+7%	+$697K	0.14%	170
2018 Q4	$8.57M	Buy	979,825 +310,725	+46%	+$3.96M	0.13%	185
2018 Q3	$11.2M	Buy	669,100 +374,600	+127%	+$8.11M	0.15%	170
2018 Q2	$6.17M	Buy	294,500 +109,500	+59%	+$2.03M	0.1%	259
2018 Q1	$2.98M	Buy	185,000 +28,000	+18%	+$555K	0.05%	389
2017 Q4	$2.98M	Buy	+157,000	New	+$2.84M	0.05%	378
2015 Q2	–	Sell	-400,000	Closed	-$2.43M	–	668
2015 Q1	$2.43M	Hold	400,000	–	–	0.05%	364
2014 Q4	$2.77M	Buy	+400,000	New	+$2.94M	0.06%	316

Other funds holding SPPI

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Macquarie Group Sydney, NSW 2000, Australia $23.2B AUM 40.19% 1-Year Est. Return

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Candriam SCA's SPPI Position: Q2 2020 in Review

Candriam SCA sold out of Spectrum Pharmaceuticals Inc (SPPI) in Q2 2020, closing a stake of 990,882 shares — an estimated $3.53M sold.

Candriam SCA first reported a position in SPPI in Q4 2014 and held it in 12 quarters. The position peaked at $11.2M in Q3 2018. 158 funds tracked by Wall St. Rank hold SPPI as of Q2 2020.

Candriam SCA reported no remaining Spectrum Pharmaceuticals Inc position as of Q2 2020 after selling out during the quarter.
Candriam SCA sold 990,882 Spectrum Pharmaceuticals Inc shares in Q2 2020, an estimated $3.53M.
Candriam SCA first reported a position in Spectrum Pharmaceuticals Inc in Q4 2014 and held it in 12 quarters.
Candriam SCA's Spectrum Pharmaceuticals Inc position peaked at $11.2M in Q3 2018.
158 funds tracked by Wall St. Rank held Spectrum Pharmaceuticals Inc as of Q2 2020.

Based on Candriam SCA's 13F filing for Q2 2020, filed 23 Jul 2020.